The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1016/j.maturitas.2021.06.013
|View full text |Cite
|
Sign up to set email alerts
|

Menopause and cardiometabolic diseases: What we (don't) know and why it matters

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
38
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(38 citation statements)
references
References 110 publications
0
38
0
Order By: Relevance
“…For example, a longer reproductive span has been linked to larger GM volumes (Schelbaum et al, 2021), lower WM brain age (Subramaniapillai et al, 2022), and lower dementia risk in older-age samples (Fox et al, 2013;Gilsanz et al, 2019;Gong et al, 2022), although contrasting results have linked a longer reproductive span to increased risk of Alzheimer's disease (AD) (Najar et al, 2020;Geerlings et al, 2001). Age at menarche and menopause are also known to have genetic components (Fernández-Rhodes et al, 2018;Wang et al, 2019;Ruth et al, 2021), but the understanding of how the genetics underlying reproductive span relate to body composition and brain structure is limited (Roa-Díaz et al, 2021). A later age at natural menopause has also been associated with lower risk for post-menopausal abdominal obesity (Zsakai et al, 2015), smaller post-menopausal increase of BMI (Montazeri et al, 2019), and decreased risk for cardiometabolic diseases (Muka et al, 2016;Roa-Díaz et al, 2021;Yang et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…For example, a longer reproductive span has been linked to larger GM volumes (Schelbaum et al, 2021), lower WM brain age (Subramaniapillai et al, 2022), and lower dementia risk in older-age samples (Fox et al, 2013;Gilsanz et al, 2019;Gong et al, 2022), although contrasting results have linked a longer reproductive span to increased risk of Alzheimer's disease (AD) (Najar et al, 2020;Geerlings et al, 2001). Age at menarche and menopause are also known to have genetic components (Fernández-Rhodes et al, 2018;Wang et al, 2019;Ruth et al, 2021), but the understanding of how the genetics underlying reproductive span relate to body composition and brain structure is limited (Roa-Díaz et al, 2021). A later age at natural menopause has also been associated with lower risk for post-menopausal abdominal obesity (Zsakai et al, 2015), smaller post-menopausal increase of BMI (Montazeri et al, 2019), and decreased risk for cardiometabolic diseases (Muka et al, 2016;Roa-Díaz et al, 2021;Yang et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Age at menarche and menopause are also known to have genetic components (Fernández-Rhodes et al, 2018;Wang et al, 2019;Ruth et al, 2021), but the understanding of how the genetics underlying reproductive span relate to body composition and brain structure is limited (Roa-Díaz et al, 2021). A later age at natural menopause has also been associated with lower risk for post-menopausal abdominal obesity (Zsakai et al, 2015), smaller post-menopausal increase of BMI (Montazeri et al, 2019), and decreased risk for cardiometabolic diseases (Muka et al, 2016;Roa-Díaz et al, 2021;Yang et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Phytoestrogens have potent antioxidants and antiinflammatory properties, particularly resveratrol and genistein. Genistein, resveratrol, and other isoflavones exhibit estrogen receptor (ER)-independent characteristics have been shown to have the ability to modify a variety of intracellular signaling systems that are essential for controlling cellular growth and protection [1][2][3][4][5][6].…”
mentioning
confidence: 99%
“…Dose, food composition, phytoestrogens delivered, and duration of usage differ significantly amongst epidemiological research, making intercomparison difficult. However, there is great interest in making valid claims about bone, breast, heart, and menopausal symptoms advantages [1][2][3][4][5][6].…”
mentioning
confidence: 99%